Excess Skin Removal After Major Weight Loss Becomes More Common with GLP-1 Medications
Individuals who lose significant weight, often using GLP-1 medications, frequently experience excess loose skin that may require surgical removal. Cases like Samantha Milton, who lost 260 pounds and underwent five procedures to address 12 pounds of excess skin, highlight the physical and mental challenges involved.
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Excess skin often remains after substantial weight loss, presenting physical and psychological challenges for affected individuals. Individuals who lose significant weight, often using GLP-1 medications, may experience excess loose skin that could require surgical removal.
This can highlight physical and mental challenges involved. Plastic surgeons report increased demand for these surgeries due to the skin's limited ability to retract.
pcos, has shared details of her pre- and post-surgery appearances. Before the procedures, she experienced rashes, itchiness, swelling, and pain in areas with loose skin. These issues persisted despite attempts to manage them with different clothing and underwear choices.
Their Purposes Plastic surgeons note that GLP-1 medications facilitate significant weight loss but do not alter the skin's biological properties.
Plastic surgeons explain that skin typically does not retract fully after major weight loss, leading to loose, hanging skin. The decision to pursue surgery is often related to quality of life, addressing issues like irritation, rashes, chafing, hygiene difficulties, discomfort with clothing, and challenges during exercise.
Some individuals who have lost substantial weight through dietary changes, bariatric surgery, and GLP-1 support face similar difficulties, including trouble finding shirts that fit without cutting into their arms. They may plan to undergo procedures like an extended brachioplasty and breast lift to address excess skin.
Excess skin can cause ongoing physical discomfort, such as sensitivity due to thin skin layers that accumulate swelling.
Mental health aspects also play a role, as individuals may struggle with the appearance and functionality of loose skin after achieving weight loss goals. Some have discussed these challenges publicly to raise awareness. Surgeons report growing interest in skin removal procedures amid the rise in GLP-1 use.
These surgeries aim to improve comfort and function rather than solely aesthetic reasons. The procedures are not necessary for everyone, and some individuals choose not to pursue them.
media has contributed to more open discussions about excess skin following weight loss.
However, societal attitudes toward body changes and surgical interventions vary. As GLP-1 medications continue to gain popularity, there may be increased demand for related plastic surgery, potentially leading to more shared experiences and medical guidance on managing post-weight loss effects.
Key Facts
Story Timeline
3 events- Past five years
Samantha Milton lost 260 pounds and underwent five skin removal surgeries.
1 sourceUsa Today - Recent period
Jenna Elizabeth lost 180 pounds and plans skin removal procedures.
1 sourceUsa Today - Ongoing
Plastic surgeons report increased demand for procedures due to GLP-1 use.
1 sourceUsa Today
Potential Impact
- 01
Individuals may face ongoing physical discomfort like rashes without surgical intervention.
- 02
Increased demand for plastic surgery procedures follows rise in GLP-1 medication use.
- 03
More public discussions on social media normalize experiences with excess skin.
- 04
Mental health support needs grow for those dealing with post-weight loss body changes.
Transparency Panel
Related Stories
The TimesTrump Nominates Dr. Nicole Saphier for Surgeon General After Previous Nominee Withdraws
President Trump announced Dr. Nicole Saphier, a 44-year-old radiologist and Fox News contributor, as his nominee for U.S. surgeon general on Thursday, following the withdrawal of Dr. Casey Means due to insufficient Senate support. Saphier, who authored a book titled Make America…
Usa TodaySupreme Court Considers Cancer Warning Requirement for Monsanto's Roundup
The U.S. Supreme Court heard arguments on whether Monsanto must add a cancer warning to its Roundup weedkiller, following a $1.25 million verdict awarded to plaintiff John Durnell. The case examines if federal EPA regulations preempt state court lawsuits over labeling. The Trump…
StatNancy Cox, Former CDC Influenza Division Leader, Dies at 77 from Glioblastoma
Nancy Cox, who led the CDC's influenza team for 22 years and contributed to global flu surveillance, died Thursday from glioblastoma. She was 77. Colleagues praised her role in pandemic preparedness and vaccine development.